Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein
Keywords: AE, adverse event; ALS, antibodies in lymphocyte supernatants; ASC, antibody secreting cell; CF, colonization factor; CT, cholera toxin; CTB, cholera toxin binding subunit; dmLT, double mutant LT; ELISA, enzyme linked immunosorbent assay; ELISPOT, enzyme